Get Started

ACET

Adicet Bio (ACET)

Adicet Bio Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACET

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
04/28/2023	5:13PM	Business Wire	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ACET	Adicet Bio Inc
04/18/2023	4:31PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ACET	Adicet Bio Inc
04/18/2023	4:29PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ACET	Adicet Bio Inc
04/13/2023	7:00AM	Business Wire	Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference	NASDAQ:ACET	Adicet Bio Inc
03/31/2023	4:31PM	Business Wire	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ACET	Adicet Bio Inc
03/15/2023	4:14PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ACET	Adicet Bio Inc
03/15/2023	4:09PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ACET	Adicet Bio Inc
03/15/2023	4:05PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACET	Adicet Bio Inc
03/15/2023	4:01PM	Business Wire	Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress	NASDAQ:ACET	Adicet Bio Inc
03/13/2023	4:00PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ACET	Adicet Bio Inc
03/10/2023	3:46PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACET	Adicet Bio Inc
03/09/2023	7:00AM	Business Wire	Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit	NASDAQ:ACET	Adicet Bio Inc
02/28/2023	5:31PM	Business Wire	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ACET	Adicet Bio Inc
02/14/2023	5:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACET	Adicet Bio Inc
02/14/2023	12:52PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACET	Adicet Bio Inc
02/14/2023	10:01AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACET	Adicet Bio Inc
02/13/2023	3:53PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ACET	Adicet Bio Inc
02/01/2023	7:00AM	Business Wire	Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference	NASDAQ:ACET	Adicet Bio Inc
01/31/2023	8:40PM	Business Wire	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ACET	Adicet Bio Inc
01/26/2023	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACET	Adicet Bio Inc
01/26/2023	4:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACET	Adicet Bio Inc
01/26/2023	4:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACET	Adicet Bio Inc
01/26/2023	4:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACET	Adicet Bio Inc
12/30/2022	4:43PM	Business Wire	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ACET	Adicet Bio Inc
12/23/2022	6:02AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ACET	Adicet Bio Inc
12/12/2022	2:20PM	TipRanks	Adicet Bio Stock Craters 36% on Phase 1 Clinical Data	NASDAQ:ACET	Adicet Bio Inc
12/12/2022	6:04AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACET	Adicet Bio Inc
12/12/2022	12:25AM	TipRanks	Adicet Bio (ACET) Gets a Buy from JMP Securities	NASDAQ:ACET	Adicet Bio Inc
12/11/2022	1:15PM	TipRanks	JonesTrading Sticks to Their Buy Rating for Adicet Bio (ACET)	NASDAQ:ACET	Adicet Bio Inc
12/10/2022	10:00AM	Business Wire	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)	NASDAQ:ACET	Adicet Bio Inc